The Efficacy of Directional Atherectomy Prior to Stent Implantation

Moussa1, Moses, Colombo

  • 1Lenox Hill Heart and Vascular Institute, Department of Interventional Cardiology, 130 E. 77th Street, 9th Floor, New York, NY 10021, USA. Imoussa@worldnet.att.net

Current Interventional Cardiology Reports
|November 30, 2000
PubMed

Insights

Directional atherectomy before coronary stenting may reduce restenosis in complex lesions. Further research and device improvements are needed to confirm its clinical use and safety for specific patient groups.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • Coronary stents improve outcomes but can lead to in-stent restenosis, particularly in complex lesions.
  • High plaque burden is a key factor inciting neointimal proliferation post-stenting.
  • In-stent restenosis remains a significant challenge in coronary interventions.

Purpose of the Study:

  • To evaluate plaque removal using directional atherectomy before stenting as a strategy to reduce in-stent restenosis.
  • To identify patient subgroups and lesion characteristics that may benefit most from this approach.
  • To outline requirements for the clinical adoption of directional atherectomy in complex coronary interventions.

Main Methods:

  • Review of prospective nonrandomized experience with directional atherectomy and stenting.
  • Analysis of factors contributing to neointimal proliferation and restenosis.
  • Identification of criteria for patient selection and procedural optimization.

Main Results:

  • Prospective nonrandomized data suggest directional atherectomy prior to stenting is a promising approach for selected patients.
  • Plaque burden is a recognized factor influencing neointimal proliferation.
  • Randomized trial results are pending to establish definitive proof of concept.

Conclusions:

  • Directional atherectomy shows potential for reducing restenosis in complex coronary lesions.
  • Clinical utility depends on device improvements, minimizing procedural complications (e.g., myocardial infarction), and patient selection.
  • High-risk patients with specific lesion types (e.g., noncalcified, large vessels, long/multiple stents, aorto-ostial, bifurcations, CTOs) may be ideal candidates.